We would like to thank our exhibitors and sponsors for sponsoring this meeting. This includes pharmaceutical companies including AstraZeneca UK, Chiesi Ltd, Orion Pharma (UK) Ltd and Pfizer Ltd. They have had no editorial input into or control over the agenda, content development or choice of speakers, nor opportunity to influence except for the sponsored symposia presentations.

Event Schedule

Wednesday, September 30, 2026
8:30 AM - 9:20 AM
Registration and Exhibition
9:20 AM - 9:30 AM
Chair’s opening remarks
Chair’s opening remarks
9:30 AM - 10:10 AM
Primary care nursing in Scotland: leadership, autonomy and future roles
  • Expanding clinical, prescribing, and leadership roles in community nursing
  • Collaborating across HSCPs and multidisciplinary teams
  • Career development pathways and training opportunities
  • Strategies for workforce sustainability and retention
10:15 AM - 10:55 AM
Implementation of the national asthma guideline for patients aged 6+
  • Discuss the risk of SABA over reliance for patients with asthma 
  • Provide an overview of the BTS/NICE/SIGN NG245 guideline for the management of asthma in people aged 12 years and over. 
  • Share real-world experience and practical insights into identifying and managing patients with asthma who may be suitable for AIR or MART, in line with national guidelines 

This is a promotional symposium sponsored and organised by AstraZeneca and is intended for UK HCPs only.

10:55 AM - 11:25 AM
Exhibition and Networking
11:25 AM - 12:05 PM
Sponsored session to be confirmed

Sponsored by:

Addiction in practice: from harm reduction to recovery
  • Recognising substance use and having confident conversations with patients 
  • Understanding harm reduction, abstinence and different approaches to recovery 
  • Managing common risks including overdose, withdrawal and infection 
  • Supporting patients into treatment and specialist services 
12:10 PM - 12:50 PM
Common dermatological conditions – Can we do better?
  • Practical treatment principles for acne, rosacea, eczema and psoriasis 
  • Optimising treatment and using advanced therapies in primary care
Right Decisions, Better Conversations: Empowering Patients to Understand Cardiovascular Risk
  • Understanding cardiovascular risk: using ASSIGN 2 to identify risk and opportunities for prevention
  • Beyond the headlines: hypertension and cholesterol management in cardiovascular prevention 
  • From understanding to action: empowering patients to reduce cardiovascular risk
12:50 PM - 1:50 PM
Lunch and Networking
1:50 PM - 2:30 PM
Sexual health in primary care: promoting safe, accessible care
  • Assessment: history, testing and common presentations
  • Prevention: PrEP, PEP, vaccines and DoxyPEP
  • Inclusive communication and high-risk groups
  • Red flags and referral pathways
Mental health support: recognising early warning signs
  • Identifying anxiety, depression, and emerging mental health issues in patients
  • Practical interventions and low-intensity therapies that can be delivered in practice
  • Recognising high-risk patients and when to escalate or refer
  • Supporting patients holistically while maintaining staff wellbeing
2:30 PM - 3:00 PM
Exhibition and Networking
3:00 PM - 3:40 PM
Women’s health: troubleshooting contraception, bleeding and menopause
  • Optimising contraception choices and counselling in primary care
  • Management of problematic bleeding in primary care
  • Menopause troubleshooting
Type 2 diabetes in 2026: aggressively holistic care
  • Why it’s not medicines or lifestyle
  • Working together to find the right strategy for each person
  • Confidence in targeted, evidence-based use of medicines
  • Practical approaches you can use immediately to improve outcomes for people living with diabetes
3:40 PM - 4:00 PM
The Big Interview

Hosted by Megan Ford, Editor, Nursing in Practice 

4:00 PM
End of Conference

If you are interested in speaking at this event, please contact Pippa Baynham, Senior Conference Producer.

If you are interested in sponsoring a talk on the Agenda, or exhibiting at the event, please contact Edward BurkleExecutive Director ​​​​​​​